Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Egypt launches major study on rare genetic disorder NF1

NCT ID NCT07221331

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 21 times

Summary

This study is a disease registry that collects information from medical records of 200 people in Egypt diagnosed with neurofibromatosis type 1 (NF1), a genetic condition that causes tumors on nerves. Researchers aim to understand how common NF1 is, how it progresses, and how it is managed in real-world settings. The study does not test any new treatment but will help doctors better recognize and care for NF1 patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS TYPE 1 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Al Mansurah, Egypt

  • Research Site

    RECRUITING

    Alexandria, Egypt

  • Research Site

    RECRUITING

    Aswān, Egypt

  • Research Site

    NOT_YET_RECRUITING

    Asyut, Egypt

  • Research Site

    RECRUITING

    Cairo, Egypt

  • Research Site

    NOT_YET_RECRUITING

    Cairo, Egypt

  • Research Site

    NOT_YET_RECRUITING

    Sohag, Egypt

  • Research Site

    RECRUITING

    Tanta, Egypt

  • Research Site

    NOT_YET_RECRUITING

    Zagazig, Egypt

Conditions

Explore the condition pages connected to this study.